FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

423 letters match. Newest first.

  1. Empacadora Bilbo S.A. DBA Bilbosa

    FDA warns Ecuadorian seafood processor Bilbosa over seafood safety plan gaps for histamine and C. botulinum.

    High risk
  2. QuVa Pharma, Inc.

    FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.

    High risk
  3. Lucky K.T. Co., Inc.

    FDA warns Lucky K.T. noodle maker over insanitary conditions, missing food safety plan, undeclared wheat.

    High risk
  4. Iowa Egg Company Inc.

    Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.

    High risk
  5. ReConserve Inc.

    FDA warned ReConserve Inc. that animal-food ingredients stored outdoors uncovered were contaminated and its preventive controls were inadequate.

    High risk
  6. Comercializadora Internacional Piscicola New Your S.A

    Colombian tilapia processor's HACCP plan omits Clostridium botulinum and drug-residue hazards, FDA says after remote assessment.

    High risk
  7. Prime Lab LLC

    Prime Lab LLC failed U.S. drug manufacturing quality rules for over-the-counter hand soaps and sanitizers, including raw-material testing and shared toxic equipment.

    High risk
  8. Jeffrey W. Taub, M.D./Children's Hospital of Michigan

    FDA warns Detroit investigator over pediatric drug trial protocol deviations and lapsed IRB approval.

    High risk
  9. Kimera Labs, Inc.

    FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.

    High risk
  10. Lone Star Botanicals Inc.

    FDA cited Lone Star Botanicals for unsanitary ready-to-eat seasonings and unapproved drug claims for Dr. Botanical Health products.

    High risk
  11. Omeza LLC

    FDA warned Omeza LLC over mold, insects and animal waste in drug manufacturing areas and unapproved nonprescription drugs.

    High risk
  12. Anish S. Shah, M.D./Siyan Clinical Research

    FDA warned clinical investigator Dr. Anish Shah that he broke blinding rules in a depression drug study, calling the site's data into question.

    Medium
  13. Dextrum Laboratories Inc.

    FDA found Dextrum Laboratories, an over-the-counter drug contract manufacturer, failed identity testing, toxic glycol checks, water monitoring, and process validation.

    High risk
  14. Cooperstown Cheese Company, LLC

    FDA found Listeria monocytogenes in Cooperstown Cheese's ready-to-eat raw milk cheese facility and cited repeated sanitation failures.

    High risk
  15. Desserts by Helen, Inc.

    FDA cited Desserts by Helen for unsanitary conditions and cleaning failures at its Louisville ready-to-eat bakery.

    High risk
  16. Cipla Limited

    FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.

    High risk
  17. Independent Seafoods Panama, S.A. dba Panama Artisanal Seafoods FQ

    FDA warned Independent Seafoods Panama over missing written seafood safety plans for fresh and histamine fish.

    High risk
  18. PESCAMOZ LDA

    FDA says PESCAMOZ lacked required seafood safety plans for tuna and swordfish, calling products adulterated.

    High risk
  19. Global Pharma Healthcare Private Limited

    FDA warned Global Pharma Healthcare that non-sterile artificial tears and eye ointment from its India plant were tied to a Pseudomonas outbreak with four deaths.

    High risk
  20. Gondi S.A.

    FDA warns Ecuadorian canned seafood maker Gondi S.A. after finding underprocessed low-acid canned shrimp and sardines linked to recalls and an import alert.

    High risk
  21. Acrostak Schweiz AG

    FDA warns Acrostak Schweiz that its M-Cath Flexy Microcatheter was marketed without required 510(k) clearance (FDA marketing permission) and has quality-system violations.

    High risk
  22. Maria W. Greenwald, M.D.

    FDA warned Dr. Maria W. Greenwald over clinical trial violations involving investigational drugs, including ineligible subjects and inaccurate records.

    High risk
  23. ALI Pharmaceutical Manufacturing, LLC

    FDA says ALI Pharmaceutical Manufacturing failed to validate and control its porcine thyroid drug substance process, making the drug substance adulterated.

    High risk
  24. Sun Pharmaceutical Industries Ltd.

    FDA warns Sun Pharmaceutical over CGMP violations in sterile injectable manufacturing at its Halol, India facility.

    High risk
  25. Fanta Seafoods

    FDA warned Fanta Seafoods that serious seafood safety plan (HACCP) and sanitation failures at its Guyana plant made mackerel and shrimp adulterated.

    High risk
  26. Antonio E. Blanco, M.D./Vista Health Research, LLC

    FDA cited Dr. Antonio E. Blanco/Vista Health Research for enrolling ineligible trial subjects and missing required safety imaging.

    High risk
  27. Luis Javier Pena-Hernandez, M.D., FCCP

    FDA warns Dr. Pena-Hernandez over ineligible subject enrollment and lapsed IRB approval for investigational drugs.

    High risk
  28. Signature Biologics, LLC

    FDA cited Signature Biologics for unapproved, unlicensed Signature Cord and serious sterile manufacturing failures.

    High risk
  29. Oceanitan, Inc.

    Oceanitan's refrigerated ready-to-eat baby food, tied to an infant botulism complaint, was made with botulinum hazards uncontrolled and insanitary conditions.

    High risk
  30. PT. Winson Prima Sejahtera

    FDA says PT. Winson Prima Sejahtera's ready-to-eat yellowfin tuna seafood safety plan lacks pathogen and histamine controls.

    High risk
  31. Kor-Chem, Inc.

    Kor-Chem, Inc. made OTC hand sanitizer drugs with manufacturing violations, including shared equipment with industrial chemicals and missing identity and microbial testing.

    High risk
  32. Reckitt/Mead Johnson Nutrition

    FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.

    High risk
  33. ByHeart, Inc.

    FDA warns ByHeart that Cronobacter contamination in infant formula and weak investigations led to release of adulterated powdered formula.

    High risk
  34. Perrigo Wisconsin, LLC

    FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.

    High risk
  35. K.C. Pharmaceuticals Inc.

    FDA warned K.C. Pharmaceuticals after inspections found manufacturing rule violations in sterile ophthalmic drugs, including inadequate contamination controls and cleaning validation.

    High risk
  36. Amor Nino Foods, Inc.

    FDA says Amor Nino Foods' ready-to-eat Hawaiian-style aku tuna sticks were made under an inadequate seafood safety plan and without required monitoring.

    High risk
  37. Lone Pine Farm

    FDA warned Lone Pine Farm that its shell eggs may be contaminated because it failed Salmonella prevention and refrigeration rules.

    High risk
  38. Sol-ti Inc.

    FDA found Sol-ti's ready-to-drink juices lacked validated pathogen controls and required safety monitoring.

    High risk
  39. Intas Pharmaceuticals Limited

    FDA warned Intas Pharmaceuticals about serious manufacturing-quality violations, including data integrity failures and inaccurate environmental monitoring, at its India drug plant.

    High risk
  40. Iso-Tex Diagnostics, Inc.

    FDA warns Iso-Tex Diagnostics over manufacturing violations that risk contamination of sterile radiopharmaceutical drugs.

    High risk
  41. Porfirios Italian Foods, Inc.

    FDA says Porfirios Italian Foods made pasta under insanitary conditions without a required food safety plan.

    High risk
  42. RenatiLabs Inc.

    RenatiLabs marketed WJMAX, a human umbilical cord-derived biologic, without a license and released a lot that failed sterility testing.

    High risk
  43. Baits and Sea Foods, S.A.

    FDA warns Baits and Sea Foods, S.A. over missing histamine, botulinum and allergen controls in mahi-mahi HACCP plan.

    High risk
  44. Stratus Biosystems, LLC dba CellGenuity Regenerative Science

    FDA warns CellGenuity over unapproved amniotic/umbilical products and serious sterility failures.

    High risk
  45. Chean Industries Dominicana S.R.L.

    FDA warns Chean Industries Dominicana over dried sea cucumbers lacking HACCP controls and sanitation records.

    High risk
  46. Eden’s Answers, Inc.

    Eden’s Answers dietary supplements are adulterated by manufacturing-rule violations and misbranded by label omissions.

    Medium
  47. Edge Biologicals Inc.

    FDA cited Edge Biologicals Inc. for repeated quality-system violations in its IVD culture media devices, including unvalidated cleaning and sterilization.

    High risk
  48. Marumo Co., Ltd.

    FDA warned Marumo Co. that its dried shaved skipjack tuna was adulterated because its seafood HACCP plan and sanitation controls were inadequate.

    High risk
  49. Fukusui Shoji Ltd.

    FDA warned Fukusui Shoji Ltd. that its fresh fish safety plan has serious gaps that make the fish unsafe under the law.

    High risk
  50. Row1 Inc. dba Regenative Labs

    FDA warned Regenative Labs that its umbilical cord products are unlicensed drugs, made under serious sterility and manufacturing failures.

    High risk